Liposome composition for the reduction of complement activation induced by liposomes

摘要

How to reduce the complement activation upon in vivo administration of liposomal formulations containing the therapeutic agent which is sealed is described. The method includes providing a liposome having a neutral lipopolymer of the polyethylene glycol-derived.